International journal of cardiology · 2025
Usefulness of STREI: A new index of right heart function in patients with immunoglobulin light chain cardiac amyloidosis.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Oike Fumi, Usuku Hiroki, Yamamoto Eiichiro, Matsukawa Yukako, Sueta Daisuke, Tabata Noriaki, Ishii Masanobu, Hanatani Shinsuke, Hoshiyama Tadashi, Kanazawa Hisanori, Arima Yuichiro, Takashio Seiji, Kawano Yawara, Oda Seitaro, Kawano Hiroaki, Tanaka Yasuhito, Ueda Mitsuharu, Tsujita Kenichi
Аннотация
AIMS: To evaluate the prognostic effect of a novel index by two-dimensional speckle-tracking echocardiography (STREI index) integrating right atrial (RA) and right ventricular (RV) strain in patients with immunoglobulin light chain (AL) cardiac amyloidosis.
METHODS: Ninety patients were diagnosed with AL amyloidosis at Kumamoto University Hospital from 2007 to 2022. Among these patients, 70 with evidence of cardiac amyloidosis and sufficient echocardiographic data at diagnosis, including RA and RV strain analysis, were retrospectively analysed. The STREI index was developed with the following formula: [2 × RV - free wall longitudinal strain (RV - FWLS) + RA strain during the reservoir phase].
RESULTS: During a median follow-up of 854 days (interquartile range, 151-1787 days), 33 deaths occurred. The STREI index was significantly lower in the all-cause death group than in the survival group (40.5 ± 19.9 vs. 57.7 ± 18.9, p < 0.01). The STREI index was significantly and independently associated with all-cause death after adjusting for left ventricular global longitudinal strain and left atrial strain during the reservoir phase (hazard ratio: 0.96, 95 % confidence interval: 0.93-0.98, p < 0.01). The optimal cut-off value was an STREI index of 50 % (sensitivity: 78 %, specificity: 72 %, area under curve: 0.80) to predict all-cause mortality using receiver operating characteristic analysis. A Kaplan-Meier analysis showed a significantly higher risk of all-cause death and cardiovascular death in patients with a low STREI index (<50 %, n = 32) than in those with a high STREI index (≥50 %, n = 38) (both p < 0.01).
CONCLUSIONS: The STREI index, which is a new index of total right heart function, might be useful for predicting the prognosis in patients with AL cardiac amyloidosis.
METHODS: Ninety patients were diagnosed with AL amyloidosis at Kumamoto University Hospital from 2007 to 2022. Among these patients, 70 with evidence of cardiac amyloidosis and sufficient echocardiographic data at diagnosis, including RA and RV strain analysis, were retrospectively analysed. The STREI index was developed with the following formula: [2 × RV - free wall longitudinal strain (RV - FWLS) + RA strain during the reservoir phase].
RESULTS: During a median follow-up of 854 days (interquartile range, 151-1787 days), 33 deaths occurred. The STREI index was significantly lower in the all-cause death group than in the survival group (40.5 ± 19.9 vs. 57.7 ± 18.9, p < 0.01). The STREI index was significantly and independently associated with all-cause death after adjusting for left ventricular global longitudinal strain and left atrial strain during the reservoir phase (hazard ratio: 0.96, 95 % confidence interval: 0.93-0.98, p < 0.01). The optimal cut-off value was an STREI index of 50 % (sensitivity: 78 %, specificity: 72 %, area under curve: 0.80) to predict all-cause mortality using receiver operating characteristic analysis. A Kaplan-Meier analysis showed a significantly higher risk of all-cause death and cardiovascular death in patients with a low STREI index (<50 %, n = 32) than in those with a high STREI index (≥50 %, n = 38) (both p < 0.01).
CONCLUSIONS: The STREI index, which is a new index of total right heart function, might be useful for predicting the prognosis in patients with AL cardiac amyloidosis.